These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2498389)

  • 1. Purification, characterization, and immunological cross-reactivity of alginates produced by mucoid Pseudomonas aeruginosa from patients with cystic fibrosis.
    Pedersen SS; Espersen F; Høiby N; Shand GH
    J Clin Microbiol; 1989 Apr; 27(4):691-9. PubMed ID: 2498389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of antibodies to Pseudomonas aeruginosa alginate extracellular polysaccharide in animals and cystic fibrosis patients by enzyme-linked immunosorbent assay.
    Bryan LE; Kureishi A; Rabin HR
    J Clin Microbiol; 1983 Aug; 18(2):276-82. PubMed ID: 6413528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of alginate-producing Pseudomonas aeruginosa on alveolar macrophage apoptotic cell clearance.
    McCaslin CA; Petrusca DN; Poirier C; Serban KA; Anderson GG; Petrache I
    J Cyst Fibros; 2015 Jan; 14(1):70-77. PubMed ID: 25027418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis.
    Pedersen SS; Espersen F; Høiby N; Jensen T
    J Clin Microbiol; 1990 Apr; 28(4):747-55. PubMed ID: 2110181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS; Høiby N; Espersen F; Koch C
    Thorax; 1992 Jan; 47(1):6-13. PubMed ID: 1539148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS
    APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody to Pseudomonas aeruginosa mucoid exopolysaccharide and to sodium alginate in cystic fibrosis serum.
    Speert DP; Lawton D; Mutharia LM
    Pediatr Res; 1984 May; 18(5):431-3. PubMed ID: 6233529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG subclass antibody responses to alginate from Pseudomonas aeruginosa in patients with cystic fibrosis and chronic P. aeruginosa infection.
    Pressler T; Pedersen SS; Espersen F; Høiby N; Koch C
    Pediatr Pulmonol; 1992 Sep; 14(1):44-51. PubMed ID: 1437343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonfatal bacteremia caused by a mucoid, alginate-producing strain of Pseudomonas aeruginosa.
    Anastassiou ED; Frangides C; Dimitracopoulos G
    Diagn Microbiol Infect Dis; 1986 Nov; 5(4):277-83. PubMed ID: 3096627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response.
    Pedersen SS; Kharazmi A; Espersen F; Høiby N
    Infect Immun; 1990 Oct; 58(10):3363-8. PubMed ID: 2401567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of mucoid strains of Pseudomonas aeruginosa from non-cystic-fibrosis patients and characterisation of the structure of their secreted alginate.
    McAvoy MJ; Newton V; Paull A; Morgan J; Gacesa P; Russell NJ
    J Med Microbiol; 1989 Mar; 28(3):183-9. PubMed ID: 2494343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative immunochemistry of lipopolysaccharides from typable and polyagglutinable Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis.
    Fomsgaard A; Conrad RS; Galanos C; Shand GH; Høiby N
    J Clin Microbiol; 1988 May; 26(5):821-6. PubMed ID: 3133386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alginate production by the mucoid Pseudomonas aeruginosa associated with cystic fibrosis.
    Gill JF; Deretic V; Chakrabarty AM
    Microbiol Sci; 1987 Oct; 4(10):296-9. PubMed ID: 3155272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa flagellin and alginate elicit very distinct gene expression patterns in airway epithelial cells: implications for cystic fibrosis disease.
    Cobb LM; Mychaleckyj JC; Wozniak DJ; López-Boado YS
    J Immunol; 2004 Nov; 173(9):5659-70. PubMed ID: 15494517
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Limoli DH; Whitfield GB; Kitao T; Ivey ML; Davis MR; Grahl N; Hogan DA; Rahme LG; Howell PL; O'Toole GA; Goldberg JB
    mBio; 2017 Mar; 8(2):. PubMed ID: 28325763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients.
    May TB; Shinabarger D; Maharaj R; Kato J; Chu L; DeVault JD; Roychoudhury S; Zielinski NA; Berry A; Rothmel RK
    Clin Microbiol Rev; 1991 Apr; 4(2):191-206. PubMed ID: 1906371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemical examination of the Pseudomonas aeruginosa glycocalyx: a monoclonal antibody which recognizes L-guluronic acid residues of alginic acid.
    Irvin RT; Ceri H
    Can J Microbiol; 1985 Mar; 31(3):268-75. PubMed ID: 3924383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide is present in immune complexes isolated from sputum in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G; Shand GH; Fomsgaard A; Høiby N
    APMIS; 1992 Feb; 100(2):175-80. PubMed ID: 1554493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients.
    Pier GB; Desjardins D; Aguilar T; Barnard M; Speert DP
    J Clin Microbiol; 1986 Aug; 24(2):189-96. PubMed ID: 2943759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Pier GB
    Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.